These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26250494)

  • 1. New potential diagnostic biomarkers for pulmonary hypertension.
    Tiede SL; Gall H; Dörr O; dos Santos Guilherme M; Troidl C; Liebetrau C; Voss S; Voswinckel R; Schermuly RT; Seeger W; Grimminger F; Zeiher AM; Dimmeler S; Möllmann H; Hamm CW; Ghofrani HA; Nef HM
    Eur Respir J; 2015 Nov; 46(5):1390-6. PubMed ID: 26250494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.
    Säleby J; Bouzina H; Lundgren J; Rådegran G
    Scand Cardiovasc J; 2017 Oct; 51(5):261-270. PubMed ID: 28776404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure.
    Paterson MA; Pilbrow AP; Frampton CM; Cameron VA; Troughton RW; Pemberton CJ; Lund M; Devlin GP; Richards AM; Doughty RN; Palmer BR
    Eur J Heart Fail; 2024 Aug; 26(8):1804-1813. PubMed ID: 38980212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J; Weiskirchen R
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Takahashi K; Matsuda Y; Suzuki M
    Hypertension; 2011 Nov; 58(5):859-66. PubMed ID: 21947468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
    Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
    Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma soluble fms-like tyrosine kinase-1 and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers.
    Nadarajah VD; Min RG; Judson JP; Jegasothy R; Ling EH
    J Obstet Gynaecol Res; 2009 Oct; 35(5):855-63. PubMed ID: 20149032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion.
    Daponte A; Pournaras S; Polyzos NP; Tsezou A; Skentou H; Anastasiadou F; Lialios G; Messinis IE
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1444-51. PubMed ID: 21715541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe preeclampsia.
    Doherty A; Carvalho JC; Drewlo S; El-Khuffash A; Downey K; Dodds M; Kingdom J
    J Obstet Gynaecol Can; 2014 Aug; 36(8):692-700. PubMed ID: 25222164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.
    McMahan Z; Schoenhoff F; Van Eyk JE; Wigley FM; Hummers LK
    Arthritis Res Ther; 2015 Aug; 17(1):201. PubMed ID: 26245195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
    Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
    Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.